BioCardia (BCDA) Non Operating Income (2016 - 2026)
BioCardia's (BCDA) quarterly Non Operating Income came in at $10000.0 in Q2 2026, up 400.0% year-over-year from $2000.0 in Q2 2025, and up 42.86% quarter-over-quarter from $7000.0 in Q1 2026.
Powered by 
Analysis
BioCardia (BCDA) Non Operating Income (2016 - 2026) Analysis & Trends
BioCardia (BCDA) has reported Non Operating Income for 11 consecutive years, with $10000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non Operating Income rose 400.0% year-over-year to $10000.0 in Q2 2026; TTM through Jun 2026 was $24000.0, a 60.0% decrease from a year earlier, with the FY2024 full-year figure at $55000.0, down 24.66% from the prior year.
- Non Operating Income was $10000.0 for Q2 2026 at BioCardia, up from $7000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $28000.0 in Q2 2023 and troughed at -$10000.0 in Q4 2022.
- A 5-year average of $9411.8 and a median of $8000.0 in 2024 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income sank 150.0% in 2022 and jumped 2900.0% in 2023, its largest moves.
- Over 5 years, Non Operating Income stood at -$10000.0 in 2022, then surged by 220.0% to $12000.0 in 2023, then surged by 108.33% to $25000.0 in 2024, then tumbled by 80.0% to $5000.0 in 2025, then soared by 100.0% to $10000.0 in 2026.
- The last three Non Operating Income figures came in at $10000.0 (Q2 2026), $7000.0 (Q1 2026), and $5000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 27.08 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 3.88 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | -2.57 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -15.04 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 1.77 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | 10,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 28,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | -10,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 3,000.00 |